Stocks
Mutual Funds
ETFs
Pro Tools
Terminal
WealthView
Pricing
Learn More
stocksVALIANTLAB
resources
VALIANTLAB

Valiant Laboratories Ltd.

NSE: VALIANTLAB
BSE: 543998
Sector: Healthcare
Industry: Pharmaceuticals
128.43-2.6 (-2.00%)
23 Oct, 12:00 AM

Annual Reports and Financial Documents

Valiant Laboratories Ltd. annual reports, quarterly results, earnings call transcripts and investor presentations. All official filings in one place.
2023202420252026
Annual Reports—FY 2024FY 2025FY 2026
Quarterly Results
Conference Calls————
Presentations————

Corporate Announcements and Regulatory Filings

Valiant Laboratories Ltd. BSE/NSE disclosures, board meeting outcomes, insider trading notifications, acquisitions and other regulatory filings.
  1. Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 201813 Oct 2026
    Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
    Please find enclosed
  2. Closure of Trading Window29 Sept 2026
    Closure of Trading Window
    Closure of Trading Window for declaration of Financial Results for the quarter and half year ended September 30, 2026.
  3. AGM29 Sept 2026
    Shareholder Meeting / Postal Ballot-Scrutinizer''s Report
    Scrutinizer''s Report and Voting Results of 5th AGM of Valiant Laboratories Limited.
  4. AGM29 Sept 2026
    Shareholder Meeting / Postal Ballot-Scrutinizer''s Report
    Scrutinizer''s Report and Voting Results of 5th AGM of Valiant Laboratories Limited.
  5. AGM28 Sept 2026
    Shareholder Meeting / Postal Ballot-Outcome of AGM
    Proceedings of 5th Annual General Meeting of Valiant Laboratories Limited held through VC/OAVM.
  6. Outcome without intimation17 Sept 2026
    Board Meeting Outcome for Investment In AMPYR Renewable Energy Resources Twelve A Private Limited
    Please find enclosed
  7. Acquisition17 Sept 2026
    Announcement under Regulation 30 (LODR)-Acquisition
    Please find enclosed
  8. Newspaper Publication4 Sept 2026
    Announcement under Regulation 30 (LODR)-Newspaper Publication
    Newspaper Advertisement regarding Completion of Dispatch of Annual Report for FY 2025-26 and Notice of 5th Annual General Meeting to the Members of the Company
  9. Credit Rating3 Sept 2026
    Announcement under Regulation 30 (LODR)-Credit Rating
    Credit Rating issued by India Ratings & Research Private Limited
  10. General3 Sept 2026
    Letter To Shareholders
    Letter to Shareholders under Regulation 36(1)(b) of SEBI (LODR) Regulations, 2015
  11. AGM3 Sept 2026
    Notice Of 5Th Annual General Meeting And Annual Report For FY 2025-26
    Notice of 5th AGM and Annual Report for FY 2025-26
  12. Reg. 34 (1) Annual Report3 Sept 2026
    Reg. 34 (1) Annual Report.
    Annual Report for FY 2025-26.
  13. Newspaper Publication31 Aug 2026
    Announcement under Regulation 30 (LODR)-Newspaper Publication
    Newspaper Advertisement w.r.t. 5th AGM of the Company.
  14. Newspaper Publication12 Aug 2026
    Announcement under Regulation 30 (LODR)-Newspaper Publication
    Copy of Newspaper Publication of Financial Results for the quarter ended June 30, 2026.
  15. Monitoring Agency Report10 Aug 2026
    Announcement under Regulation 30 (LODR)-Monitoring Agency Report
    Monitoring Agency Report for the quarter ended June 30, 2026
  16. General10 Aug 2026
    Opening Of A New Corporate Office Of The Company
    Opening of a new Corporate Office of the Company
  17. Change in Registered Office Address10 Aug 2026
    Announcement under Regulation 30 (LODR)-Change in Registered Office Address
    Change in the Registered Office address of the Company, subject to the approval of shareholders and other Statutory Authorities.
  18. Acquisition10 Aug 2026
    Announcement under Regulation 30 (LODR)-Acquisition
    Investment in Wholly Owned Subsidiary.
  19. Change in Directorate10 Aug 2026
    Announcement under Regulation 30 (LODR)-Change in Directorate
    Re-appointment of Managing Director, Independent Director and Continuation of Directorship of Non- Executive Director.
  20. Outcome of Board Meeting10 Aug 2026
    Board Meeting Outcome for Audited Standalone And Consolidated Financial Results For Quarter Ended June 30, 2026.
    Audited Standalone and Consolidated Financial Results for the quarter ended June 30, 2026.

Frequently Asked Questions

Where can I download the annual report of Valiant Laboratories Ltd.?
Annual reports of Valiant Laboratories Ltd. are available for download in the Annual Reports and Financial Documents section of the Resources tab, organised by financial year.
Where can I find the quarterly results of Valiant Laboratories Ltd.?
Quarterly earnings results and presentations of Valiant Laboratories Ltd. are available in the Annual Reports and Financial Documents section of the Resources tab. Detailed financials are also in the Statements tab.
Does Valiant Laboratories Ltd. publish earnings call transcripts?
Earnings call transcripts of Valiant Laboratories Ltd., where available, are listed in the Annual Reports and Financial Documents section of the Resources tab.
Where can I find investor presentations of Valiant Laboratories Ltd.?
Investor presentations and annual day presentations of Valiant Laboratories Ltd. are listed in the Resources tab under Annual Reports and Financial Documents.
What are the recent corporate announcements of Valiant Laboratories Ltd.?
Corporate announcements and regulatory filings of Valiant Laboratories Ltd. as submitted to BSE and NSE are available in the Corporate Announcements and Regulatory Filings section of the Resources tab.
How do I access the regulatory filings of Valiant Laboratories Ltd.?
Regulatory filings including board meeting outcomes, insider trading disclosures and other exchange notifications of Valiant Laboratories Ltd. are in the Corporate Announcements and Regulatory Filings section of the Resources tab.
What is the ISIN of Valiant Laboratories Ltd.?
The ISIN (International Securities Identification Number) of Valiant Laboratories Ltd. is INE0JWS01017. This is the unique identifier used across exchanges and depositories.
On which stock exchange is Valiant Laboratories Ltd. listed?
Valiant Laboratories Ltd. is listed on NSE and BSE. The NSE symbol is VALIANTLAB and the BSE code is -.
Where can I find the shareholding pattern of Valiant Laboratories Ltd.?
The quarterly shareholding pattern of Valiant Laboratories Ltd. showing promoter, FII, DII, mutual fund and public holdings is available in the Shareholding Pattern section on the Overview tab.
How current is the data for Valiant Laboratories Ltd. on Sharpely?
Share price data for Valiant Laboratories Ltd. is updated as of 23 Oct 2026. Financial statements, shareholding and other fundamental data are updated after each quarterly disclosure.